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Abstract
Background: Although the satellite cell (SC) is a key regulator of muscle growth during development and muscle
adaptation following exercise, the regulation of human muscle SC function remains largely unexplored. STAT3 signalling
mediated via interleukin-6 (IL-6) has recently come to the forefront as a potential regulator of SC proliferation. The early
response of the SC population in human muscle to muscle-lengthening contractions (MLC) as mediated by STAT3 has not
been studied.
Methodology/Principal Findings: Twelve male subjects (2162y ; 8 3 612 kg) performed 300 maximal MLC of the
quadriceps femoris at 180uNs
21 over a 55u range of motion with muscle samples (vastus lateralis) and blood samples
(antecubital vein) taken prior to exercise (PRE), 1 hour (T1), 3 hours (T3) and 24 hours (T24) post-exercise. Cytoplasmic and
nuclear fractions of muscle biopsies were purified and analyzed for total and phosphorylated STAT3 (p-STAT3) by western
blot. p-STAT3 was detected in cytoplasmic fractions across the time course peaking at T24 (p,0.01 vs. PRE). Nuclear total
and p-STAT3 were not detected at appreciable levels. However, immunohistochemical analysis revealed a progressive
increase in the proportion of SCs expressing p-STAT3 with ,60% of all SCs positive for p-STAT3 at T24 (p,0.001 vs. PRE).
Additionally, cMyc, a STAT3 downstream gene, was significantly up-regulated in SCs at T24 versus PRE (p,0.05). Whole
muscle mRNA analysis revealed induction of the STAT3 target genes IL-6, SOCS3, cMyc (peaking at T3, p,0.05), IL-6Ra and
GP130 (peaking at T24, p,0.05). In addition, Myf5 mRNA was up-regulated at T24 (p,0.05) with no appreciable change in
MRF4 mRNA.
Conclusions/Significant Findings: We demonstrate that IL-6 induction of STAT3 signaling occurred exclusively in the nuclei
of SCs in response to MLC. An increase in the number of cMyc+ SCs indicated that human SCs were induced to proliferate
under the control of STAT3 signaling.
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Introduction
Muscle satellite cells (SCs) are a population of cells that reside
between the sarcolemma and basal lamina of myofibres [1] and
have been shown to play an integral role in skeletal muscle repair
[2], hypertrophy [3,4], and hyperplasia [5,6], in humans and
animals. Although SCs are key regulators of muscle growth during
development and muscle adaptation following exercise [7–15], the
cellular regulation of human muscle SC function remains largely
unexplored. Undoubtedly, the orchestration of events that govern
SC function following damage involves a complex milieu of factors
originating from the SC in addition to niche factors extrinsic to the
SC [16]. Identified regulators of human SCs include insulin like
growth factor-1 [17], hepatocyte growth factor [18], transforming
growth factor beta [19] and Notch/Delta [7]. Recently,
interleukin-6 (IL-6) has been implicated as playing a role in the
regulation of human SCs in response to damaging eccentric
contractions [20].
Traditionally, IL-6 was considered an inflammatory cytokine
[21], however, recent work has shown that IL-6 is produced by
muscle [22], released into circulation [23] and can act on the
muscle cells themselves. As such, IL-6 is now also referred to as a
‘‘myokine’’ [24,25]. Importantly, IL-6 knockout mice demonstrat-
ed a blunted hypertrophic response and less SC-mediated
myonuclear accretion compared to wild-type mice following
compensatory hypertrophy [26]. Furthermore, SCs from IL-6
2/2
mice demonstrated an impaired proliferative capacity, both in vivo
and in vitro, which was shown to be related to a lack of IL-6-
mediated signal transducer and activator of transcription-3
(STAT3) signalling [26]. We have recently reported an increase
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17392in IL-6 protein localized in SCs 24 hours following a damaging
bout of muscle-lengthening contractions (MLC) in humans
coinciding with an increase in cyclin D1 expression and SC
number [20]. These data indicate that IL-6, acting via the janus
kinase 2 (JAK2)/STAT3 signalling pathway, may be involved in
SC proliferation/activation.
STAT3 is a downstream target of IL-6 [27,28], and in response
to IL-6 binding, STAT3 is phosphorylated via JAK2. This leads to
the subsequent homodimerization and translocation of p-STAT3
to the nucleus [29]. Once in the nucleus, p-STAT3 binds to the c-
interferon activation sequence (GAS) element where it then
promotes the transcription of downstream genes [30]. These
genes have been shown to be responsible for a number of cellular
functions including proliferation, migration, as well as anti-
apoptotic functions [26]. cMyc is a downstream target gene in
the STAT3 signalling cascade. It has been shown to regulate cell-
cycle kinetics through the up-regulation of a number of Cyclin
proteins which are involved in the cell growth phase G1 [31–33].
Furthermore, STAT3 also regulates a number of its upstream
signalling cascade members including IL-6, GP130, IL-6Ra and
suppressor of cytokine signalling 3 (SOCS3). The STAT3 pathway
is regulated in a negative feedback loop through interactions with
JAK2 [34]. SOCS3 can bind phosphotyrosines on JAK2 and
physically block STAT3 from binding to JAK2. Additionally,
SOCS3 can recruit ubiquitin-transferases leading to the ubiqui-
tination and degradation of JAK2 [29].
Based on previous work by McKay and colleagues (2009)
showing that p-STAT3 co-localized with SCs we aimed to
quantify SC localized p-STAT3 signalling over a time course.
We hypothesized that the mRNA species of the IL-6/STAT3
signalling cascade would be up-regulated early following the MLC
protocol along with a similar increase, as reported previously by
McKay and colleagues (2009), in the IL-6
+/Pax7
+ cell population.
Furthermore, using a time course directed at capturing STAT3
phosphorylation, we hypothesized that we would observe an
increase in p-STAT3 specifically in the SC population coinciding
with an increase in SC number. In addition, we hypothesized that
cMyc, a downstream product of STAT3 signalling, would be
detected with mRNA up-regulated in whole muscle and protein
co-localized to SCs following an increase in STAT3 signalling in
the SC population.
Results
To confirm that the MLC protocol caused muscle damage we
examined serum creatine kinase (CK) levels over the time course.
Serum CK peaked 24 hours post MLC, increasing over 300%
from PRE levels (p,0.05 vs. PRE) (figure 1a). Serum IL-6 also
peaked 24 hours post-MLC (p.0.05 vs. PRE), as well, increasing
over 200% from PRE (figure 1b). These measures were correlated
indicating a relationship between muscle damage and serum IL-6
(R
2=0.3055; p,0.001) (figure S1a)
In response to acute muscle damage we observed a 26.6%
increase in Pax7
+ cells 24 hours following the MLC protocol.
Pax7
+ cells per 100 myofibers increased from 15.5 at PRE to 19.6
(p,0.05) 24 hours post exercise. When expressed as a percentage
Figure 1. Serum measures and Pax7 positivity. (1a) Average serum CK response in U/L. (1b) Average serum IL-6 response in pg/mL; note the
similar serum responses between IL-6 and CK. (1c) Myf5 mRNA expression relative to GAPDH, expressed as fold change from PRE. (1d) Pax7
+ cells as a
percentage of total myonuclei over the time-course. (1e) Representative image at 406 magnification of a Pax7/Laminin stain with Pax7 in red,
Laminin in green and DAPI in blue. Values are reported as mean 6 S.E.M. *p,0.05 vs. PRE; { p,0.05 vs. T1, { vs. T3.
doi:10.1371/journal.pone.0017392.g001
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number (,3% at PRE to ,4.5% 24 hours post) (p.0.05
(figure 1d)). Satellite cells were quantified using a Pax7/Laminin
co-stain (figure 1e) to ensure that all Pax7 cells were in the SC
niche. Furthermore, myogenic regulatory factor 5 (Myf5), known
for its role in SC proliferation was significantly up-regulated 1.8
fold 24 hours following the MLC (p,0.05) (figure 1c), while no
significant change was observed for myogenic regulatory factor 4
(MRF4) (data not shown), known for its role in differentiation.
The number of SCs expressing IL-6 was quantified (figure 2a–
d). While there were relatively few co-positive SCs PRE, there was
a significant increase in IL-6
+/Pax7
+ cells at 3 and 24 hours post
MLC vs. PRE (p,0.05) with the peak observed at 3 hours post
where 75% of Pax7
+ cells were co-positive for IL-6 (figure 2e).
Previous attempts to quantify the STAT3 response did not show
a significant change at the whole muscle level, thus the nuclear and
cytoplasmic fraction of whole muscle was examined for a more
specific analysis. Purity was assessed using lactate dehydrogenase
(LDH) as a nuclear marker and p84 as a cytoplasmic marker
(figure S1b). Cytoplasmic p-STAT3 was significantly up-regulated
24 hours vs. PRE (p,0.05) when measured against t-STAT3
which remained unchanged over the time course (figure 3a). When
the nuclear fractions were analysed; however, no detectable p-
STAT3 and only traces of t-STAT3 were observed (figure 3b).
JAK2 was also analyzed in the cytoplasmic fraction (figure 3c).
The ratio of p-JAK2 to t-JAK2 was not significantly different at
any time point (figure 3d).
Although changes in p-STAT3 were not detectable in the
enriched nuclear fractions via western blot, immunofluorescent
analysis of p-STAT3 (figure 4a–b) illustrated an increase in p-
STAT3
+/Pax7
+ cells as a percentage of total Pax7
+ cells ranging
from 20% PRE to 40% at 1 hour, 50% at 3 hours, and 60% at
24 hours (all significantly different vs. PRE p,0.05) (figure 4c).
Diffuse p-STAT3 staining was observed throughout the muscle
fibres and appeared to intensify over the time course (figure 4a–b),
which agreed with the increased cytoplasmic p-STAT3 at
24 hours post observed using western blot analysis. Importantly,
the diffuse p-STAT3 observed in the fibre almost never co-
localized with non-satellite cell myonuclei. To further verify that p-
STAT3 signalling was indeed occurring, downstream target genes
of STAT3 were analyzed. IL-6 mRNA peaked at 3 hours, up
approximately 150 fold from PRE (p,0.05) and remained
Figure 2. IL-6/Pax7 co-localization. (2a) Representative merged image of a muscle cross-section at 406magnification stained for IL-6 in green,
Pax7 in red, and nuclei in blue being DAPI
+. The scale bar is 50 mm. (2b–e) 1006magnification image of the inset box in 2a. Scale bar is 10 mm( 2b)
DAPI
+ nuclei. (2c) Pax7
+ nuclei. Note only one of the nuclei is Pax7 positive showing the specificity of the Pax7 stain (2d) IL-6
+ nuclei. Note that both
nuclei are IL-6 positive while there is less intense IL-6 staining in the fiber itself. (2e) Merged image showing the co-localization of DAPI, IL-6 and Pax7.
(2f) IL-6
+ cells as a percentage of Pax7
+ cells. Values are reported as mean 6 S.E.M. *p,0.05 vs. PRE.
doi:10.1371/journal.pone.0017392.g002
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Both IL-6Ra (figure 5b) and GP130 (figure 5c) mRNA showed
significant increases peaking at 24 hours up 7 fold from PRE
(p,0.05) and 4.5 fold from PRE (p,0.05) respectively. SOCS3 also
increased, peaking at 3 hours, up 13 fold (p,0.05) and remaining
elevated at 24 hours up 8 fold (p,0.05) (figure 5d) from PRE.
Furthermore, the expression of SOCS3 was positively correlated
(R
2=0.5984, p,0.001) with the expression of IL-6 across time
(figure S1c). The cell-cycle related gene cMyc was robustly up-
regulated from PRE over the entire time course peaking at 4 hours
up 15 fold (p,0.05) (figure 6a). cMyc mRNA was positively
correlated with IL-6 mRNA (R
2=0.2876, p,0.001) (figure S1d)
and SOCS3 mRNA (R
2=0.5406, p,0.001) (figure S1e) illustrating
a positive relationship in the temporal expression of these STAT3
target genes.
To further verify the mRNA data illustrating an increased
expression of cMyc, immunohistochemical analysis of cMyc was
coupled with Pax7 in serial sections (figure 6c–d) and the number
of cMyc
+/Pax7
+ cells was quantified PRE and 24 hours following
MLC. The percentage of cMyc
+/Pax7
+ cells was significantly
increased at 24 hours (,40%) versus PRE (,9%) (figure 6b). This
provides additional evidence that the STAT3 signalling cascade
was active as a consequence of the bout of MLC in SCs leading to
proliferation of the SC population.
Discussion
Cell proliferation is a complex process regulated by a number of
factors, such as IL-6, IGF-1, HGF and TNFa [17,35,26,18,36],
among others. It is a process vital for continued functional capacity
and overall tissue survival of skeletal muscle. Skeletal muscle fibres
are post-mitotic thus the satellite cell (SC) is the exclusive source of
new nuclei for the maintenance of healthy skeletal muscle. Here
we illustrate the potential of STAT3 signalling in promoting SC
proliferation following acute muscle damage in humans. We have
demonstrated that following muscle damage, phosphorylated
STAT3 (p-STAT3) in SCs increases early (within one hour),
inducing downstream target genes (i.e. GP130 and SOCS3), which
further regulate the increase in STAT3 production and response
(as induced via IL-6), leading to increased cMyc expression, which
Figure 3. Nuclear and cytoplasmic expression of STAT3 and JAk2. (3a) Ratio of phosphorylated to total STAT3 protein in the cytoplasmic
fraction. (3b) Representative images of p-STAT3 and t-STAT3 in both the cytoplasmic and the nuclear fraction. (3c) Representative images of p-JAK2
and t-JAK2 in the cytoplasmic fraction. (3d) Ratio of phosphorylated to total JAK2 in the cytoplasmic fraction. Values are reported as mean 6 S.E.M.
*p,0.05 vs. PRE.
doi:10.1371/journal.pone.0017392.g003
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percentage of total myonuclei (,2–7%), even when the nuclear
fraction of whole muscle homogenate was analyzed, no p-STAT3
was observed. This lack of observable p-STAT3 in the nuclear
fraction combined with the increase in p-STAT3
+/Pax7
+ cells,
measured via immunohistochemistry strongly support the premise
that p-STAT3 signalling occurred almost exclusively in SCs in
human muscle. Further evidence is provided by the expansion of
the cMyc
+/Pax7
+ cell population from PRE to 24 hours expressed
as a percentage of total Pax7
+ cells. Collectively, the time-course
utilized in this study was successful in capturing a rapid up-
regulation in p-STAT3 signalling in SCs shown to be associated
with an increase in SC number following exercise induced muscle
injury.
In agreement with previous studies [20], IL-6 mRNA and
protein in both the blood and co-localized to the SC increased in
response to MLC. The ,1.5 fold increase in serum IL-6 supports
a number of studies reporting that IL-6 is released from the muscle
into circulation in response to MLC [20,25,37]. IL-6 mRNA was
significantly up-regulated 3 hours and 24 hours post MLC, up
,150 fold and ,100 fold respectively. While the fold changes
were of a greater magnitude in this study than in McKay and
colleagues (2009), most likely due to the dietary controls and the
training status of the subjects, the directional temporal pattern of
Figure 4. p-STAT3
+/Pax7
+ cells. (4a) Representative merged image of PRE at 406magnification with inset box showing (a-i) DAPI
+ nuclei, (a-ii)
Pax7
+ nuclei, (a-iii) no p-STAT3 stained nuclei and (c-iiii) a merged image. (4b) Representatvie merged image of T3 at 406magnification with inset
box showing (b-i) DAPI
+ nuclei, (b-ii) Pax7
+ nuclei, (b-iii) p-STAT3
+ nuclei and (b-iiii) a merged image showing co-localiztion. Note that punctate p-
STAT3 is not present at PRE but co-localizes with Pax7 at T3 and that there is an increase in diffuse fiber staining that occurs from PRE to T3. (4c)
Percentage of p-STAT3
+ SC as quantified over the time course peaking at T24. Values are reported as mean 6 S.E.M. *p,0.05 vs. PRE.
doi:10.1371/journal.pone.0017392.g004
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+/
Pax7
+ cells increased from PRE, where there were relatively few
co-positive cells, to a peak at 3 hours where approximately 75% of
all SCs were IL-6
+. IL-6
+/Pax7
+ cells remained significantly up-
regulated from PRE at 24 hours, with approximately 60% of
Pax7
+ cells expressing IL-6. It is known that SCs express the IL-
6Ra [38,20] allowing for IL-6 signalling to occur. Thus, an
increase in SC mediated IL-6 synthesis suggests that IL-6
signalling occurs in an autocrine/paracrine fashion. As a
consequence, we suggest that increased IL-6 signalling leads to
the induction of p-STAT3 signalling in the SC as evidenced by the
increases in the p-STAT3
+/Pax7
+ population and the up-
regulation of p-STAT3 regulated genes.
Previously p-STAT3 was found to be localized in the SC
compartment; however, quantification of p-STAT3 over a time-
course was not conducted in that study [20]. To verify that p-
STAT3 regulated the SC response, we quantified p-STAT3
immunofluorescence. The proportion of p-STAT3
+ SCs was
significantly elevated at T1 with ,40% of SCs co-positive and
peaking at T24 where ,60% of SCs were co-positive, similar to
that of IL-6
+ SCs. Importantly, this early increase in p-STAT3
+
SCs verifies the rapid signalling of this system and confirms that
the timing of these events were indeed occurring early as proposed
by McKay et al. [20]. This provides temporal evidence that
following a bout of damaging exercise, STAT3 is phosphorylated
leading to downstream signalling events resulting in proliferation
of human SCs. The significant increase in Pax7
+ cells, the up-
regulation of Myf5 mRNA (a major regulator of SC proliferation)
coupled with no significant change in MRF4 mRNA (a major
regulator of SC differentiation) and an increase in the percentage
of cMyc
+ SCs 24 hours after the MLC provide further evidence
that human SC proliferation involved p-STAT3 signalling. In
addition, because almost no other nuclei other than SCs were
positive for p-STAT3 and the nuclear fraction western blots
detected virtually no p-STAT3 as they were not sensitive enough
to detect such a small percentage of cells expressing p-
STAT3protein, it would appear that the IL-6 induced STAT3
signalling cascade occurred almost exclusively in SCs. This
supports the observational report from McKay and colleagues
who found that p-STAT3 was co-localized to SCs 4 hours after
subjects had preformed 300 MLC [20] and work done by Kami &
Senba who co-localized p-STAT3 to c-Met
+ cells in rats following
freeze crush injury [39]. Trenerry and colleagues also showed a
transient response in myonuclei expressing p-STAT3 2 hours
following leg extension exercise [28], however no SC specific
analysis was conducted in that study.
It is also worth noting that there was a progressive increase in p-
STAT3 staining in the muscle fibers over the time-course. This
agrees with the stepwise increase in p-STAT3 observed in the
cytoplasmic fraction. This may be explained by additional cellular
functions of p-STAT3. p-STAT3 has been implicated in
microtubule remodelling, matrix metalloproteinase production
[40,41], and focal adhesion protein production [42,41], leading to
increased migratory potential of different cell types such as
inflammatory and SCs. In addition, p-STAT has also been shown
to play a role in regulating the general hypertrophic response
Figure 5. STAT3 downstream genes. (5a) IL-6, (5b) IL-6Ra,( 5c) GP130 and (5d) SOCS3 mRNA expression relative to GAPDH, expressed as fold
change from PRE. Values are reported as mean 6 S.E.M. *p,0.05 vs. PRE; { p,0.05 vs. T1, { vs. T3.
doi:10.1371/journal.pone.0017392.g005
STAT3 Regulation of Satellite Cell Proliferation
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17392through its interactions with the leptin receptor in skeletal muscle
[43], and angiotensin II in cardiac muscle [44]. Possibly, in
response to muscle fiber damage, STAT3 is phosphorylated in
damaged myofibers acting as a localized chemotactic stimuli for
the SC and inflammatory cell populations to migrate toward. This
allows for expeditious repair via phagocytosis of necrotic or
damaged tissues [45], breakdown of connective tissues through
matrix metalloproteinase activity [46] and efficient migration of
SCs to the areas of damage [47].
There was no significant increase in p-JAK2 protein at any of
the time points. As an upstream regulator of STAT3 phosphor-
ylation we would expect a temporal profile for JAK2 phosphor-
ylation similar to that of STAT3. Since cytoplasmic p-STAT3
peaked at 24 hours following MLC it is possible that we missed the
increase in p-JAK2 as it may have occurred sometime between 3
and 24 hours.
In addition to the increase in serum IL-6 and IL-6 mRNA, we
also observed an up-regulation of several STAT3-related down-
Figure 6. cMyc
+/Pax7
+ quantification at Pre and T24. (6a) cMyc mRNA relative to GAPDH, expression represented as fold changes from PRE.
(6b) cMyc
+ SC as a percentage of Pax7
+ cells between Pre and T24, n=7. (6c & 6d) Serial sections of the same muscle cross-section with higher
magnification (1006) boxes showing the same nuclei in both images. (6c) Representative image at 206magnification of a merged Pax7/Laminin
costain where (c-i) Pax7 is in green, (c-ii) DAPI
+ nuclei are in blue and (c-iii) laminin in red. Note the two Pax7
+ nuclei which have been highlighted to
show their individual Pax7 positivity, DAPI staining and location within the laminin boarder. These nuclei are highlighted again in (6d) where the
same cells have been stained colourometrically for cMyc. (d-i) A magnified image of the inset box showing the brown cMyc staining co-localized to
the nuclear marker hematoxalin The brown cMyc positive cells are clearly within the visible fiber boarder. *p,0.05 vs. PRE.
doi:10.1371/journal.pone.0017392.g006
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serves as a negative regulator of JAK/STAT signalling. SOCS3
functions via a classic feedback inhibition loop. Production of
SOCS3 is up-regulated in response to JAK/STAT signalling
whereby it then acts to suppress JAK/STAT signalling by
inhibiting the activity of JAK2 kinase [34,29]. Importantly, the
temporal expression of SOCS3 was closely related to the temporal
expression of IL-6 with a peak at 3 hours and remaining elevated
at 24 hours post MLC. cMyc, a gene known to promote
proliferation, and that is expressed downstream of STAT3 [32],
was also associated with the same pattern of temporal expression
as IL-6 and SOCS3 following MLC, as demonstrated through
significant correlations with each of these genes (figures S1d–e).
Two other necessary members of this signalling cascade are the
receptor sub-complexes IL-6Ra and GP130. They both revealed
increases in their mRNA expression over the time course with a
peak at 24 hours. This is important as both of these mRNA species
are up-regulated in response to STAT3 signalling and serve to
autoregulate the pathway.
Providing yet another level of support for STAT3 mediated SC
proliferation was the increase in the number of cMyc
+/Pax7
+ cells
observed at T24 versus PRE. Previous work by McKay and
colleagues [20] did not localize the downstream signalling events
of the STAT3 pathway to the SC, looking only at different mRNA
species in whole muscle. Importantly, this work definitively shows
that the change observed in cMyc mRNA translates into significant
protein expression specifically in the SCs during a time when these
cells were proliferating. This implicates STAT3 as a primary
inducer of SC proliferation in human muscle following MLC. The
cMyc
+/Pax7
+ population was only analysed PRE and 24 hours
post MLC as this was the time when the highest levels of
proliferation were occurring as evidenced by the significant
increase in Pax7
+ cells. cMyc is a critical regulator of the cell
cycle, responsible for the transition from G1 to S phase [48]. It has
also been shown to be up-regulated in response to IL-6 signalling
[49] and in a STAT3 induced GP130 mediated manner [32]. One
of its main downstream functions is to regulate the production of
CyclinD1, a known regulator of the cell cycle, which we have
previously reported to increase in response MLC. The increase in
SCs expressing cMyc serve as direct evidence that p-STAT3
signalling is occurring in SCs leading to their proliferation.
The STAT3 signalling cascade as induced by IL-6 has been
shown here to be an important regulator for the proliferation of
SCs early following a muscle damaging protocol. Collectively, we
have shown that SCs up-regulate IL-6 following damage which
likely acts in an autocrine/paracrine fashion to promote
proliferation through STAT3 signalling. This IL-6 induced
STAT3 signalling is evidenced by the up-regulation of the
downstream genes regulated by p-STAT3. Furthermore, with p-
STAT3 being observed almost exclusively in SCs, not in other
myonuclei and only to a large degree at least 1 hour post muscle
damage, it appears that it acts in a very specific manner through
IL-6 leading to the proliferation of SCs and subsequent repair of
muscle damage. Thus, as evidenced by the induction of cMyc
protein it appears that STAT3 is a key signalling molecule in
human SCs in response to physiological levels of muscle damage
and contributes to the robust proliferation of SCs in the acute
period following damage.
Materials and Methods
Ethics Statement
All subjects were informed of the procedures and the potential
risks associated with the study and gave written informed consent.
This study was approved by the Hamilton Health Sciences
Research Ethics Board (08-413) and conformed to the Declaration
of Helsinki regarding the use of human subjects as research
participants.
Subjects
Twelve healthy males (age 21.261.6 yrs, height 178.265.5 cm
and weight 82.6611.5 kg) were recruited from the McMaster
University community. Subjects were sedentary having done no
lower body resistance exercise for at least the past 6 months and
were non-smokers. Subjects were told to refrain from doing any
moderate or strenuous exercise for two days prior to and during
the study.
Muscle Damage Protocol
The muscle damage protocol was preformed as described
previously [50]. Briefly, subjects completed 300 unilateral
isokinetic eccentric contractions of the quadraceps femoris using a
Biodex dynamometer (Biodex-System 3, Biodex Medical Systems,
Inc., Shirley USA) at 180uNs
21 over a 55u range of motion
[20,17,18]. The experimental leg was chosen as the dominant leg.
During each set investigators provided verbal encouragement so as
to elicit maximal effort from the subjects. The entire duration of
the protocol was approximately 30 min of which the muscle was
under tension for about 10 min.
The protocol employed in the present study has previously been
shown to cause physiological muscle damage as evidenced by
increased serum creatine kinase (CK) [50–52], z-band streaming
[53,54], desmin disruption, a significant infiltration of the
inflammatory related macrophages and neutrophils, as well as a
significant myogenic response leading to an increase in satellite cell
number based on both Pax7 and NCAM staining [20,17,18].
Muscle Biopsies
Subjects reported to the lab at either 7, 7:30, or 8am having
completed an overnight fast. Upon arrival to the lab subjects
rested, had their PRE blood draw taken from the antecubital vein
and then underwent the muscle damaging protocol. Once the
subjects had completed the protocol they had one hour to rest.
One hour post muscle damage the subjects had a second blood
draw taken as well as two muscle biopsies; one from the exercise
leg (T1) and one from the control leg (PRE). Three hours after the
protocol the subjects had a third blood draw taken along with
another biopsy from their exercise leg (T3). Subjects were then
given a meal replacement beverage (Ensure, Abbott Laboratories,
Abbott Park, Illinois, U.S.A.) The subjects were instructed to
refrain from taking any anti-inflammatory drugs or doing any
vigorous exercise. The subjects arrived the next morning at 8,
8:30, or 9am in a fasted state for the final (T24) blood draw and
biopsy from the exercised leg.
Muscle biopsies were obtained using the percutaneous needle
[55,56] method using manual suction from the vastus lateralis
under local anaesthetic (1% lidocaine) as described previously
[57]. In total, four muscle biopsies were obtained from each
subject, three in the exercise leg and one in the control leg (non-
exercise leg). The muscle tissue was dissected free of adipose and
connective tissue. The tissue was immediately divided into four
sections for RNA and protein (western blotting and immunohis-
tochemical) analysis, three of which were flash-frozen in liquid
nitrogen and stored at 280uC for later analysis and the final piece
embedded in Optimal Cutting Temperature (OCT) compound
embedding medium and frozen in liquid nitrogen cooled
isopentane.
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Blood samples were obtained from the antecubital vein
immediately prior to the intervention and then again concurrently
with the muscle biopsies one, three, and twenty-four hours after
the muscle damage protocol. Approximately 8 mL of blood was
taken from each subject at each time point. 4 mL was drawn into a
heparinised tube while the other 4 mL was drawn into a non-
heparinized tube to obtain plasma and serum samples respectively.
Samples were allowed to sit on ice (plasma) or at room
temperature (serum) for 15 minutes, centrifuged at 4000 RPM
for 15 minutes, aliquoted into 600 mL aliquots and frozen down at
280uC for later analysis.
Serum analysis was conducted for both creatine kinase activity
and IL-6 protein. Creatine kinase activity was analysed using a
commercially available kit (Pointe Scientific, Inc., Canton USA)
with modifications to the protocol to allow for running the samples
at 25uC. This included adding additional sample using a ratio
obtained from the International Federation of Clinical Chemistry
(IFCC) for conversion between 37uC and 25uC. Additionally,
sample absorbance was measured every twenty seconds for twenty
minutes to obtain the slope of the change in absorbance/minute.
This value was used to calculate the concentration of creatine
kinase in international units (U/L) which is defined as the amount
of enzyme that catalyzes the transformation of one micromole of
substrate per minute.
Serum IL-6 was analysed using a commercially available high
sensitivity Quantikine Enzyme-Linked ImmunoSorbent Assay
(ELISA) kit according to the manufacturer’s instructions (R&D
systems Inc., Minneapolis USA). Samples were run in duplicate
with all subjects on the same plate and an intra-assay CV of 6.9%.
RNA Isolation
RNA was isolated was conducted as previously described [20].
RNA isolation was conducted using Trizol Reagent (Invitrogen
Corporation, Carlsbad USA) and RNA purification was done
using the Qiagen RNeasy mini kit (Qiagen Sciences, Mississauga
Canada). The RNA was then quantified using a spectrophotom-
eter (NanoDrop 1000, Thermo Fisher Scientific Inc., Wilmington
USA).
Reverse Transcription (RT)
RNA was transcribed to cDNA using Applied Biosciences High
Capacity cDNA reverse Transcription Kit (Applied Bioscience,
Foster City USA). Individual samples in 20 mL reactions were
reverse transcribed into cDNA using an Eppendorf Mastercycle
epigradient thermal cycler (Eppendorf, Mississauga Canada).
Quantitative Real-Time Polymerase Chain-Reaction (qRT-
PCR)
qRT-PCR was performed in 25 mL reactions using SYBR
Green/Rox master mix (SuperArray Bioscience Corp., Frederick
USA). Primers were custom made using published sequences (table
S1). They were resuspened in 16 TE buffer (10 mM Tris-HCL,
0.11 mM EDTA) and frozen at 220uC until use. Using 0.2 mL
PCR tubes (Axygen Inc., Union City USA) 12.5 mL of SYBR
green, 2 mL forward primer, 2 mL reverse primer, 6.5 mLo r
7.5 mLo fH 2O depending on the cDNA template volume, 1 mLo r
2 mL was added depending on the amount necessary for the
particular gene of interest (25 ng cDNA or 50 ng cDNA). qRT-
PCR was performed using a Stratagene Mx3000P real-time PCR
system (Stratagene, Santa Clara USA) and Stratagene MXPro
QPCR Software Version 3.00 (Stratagene, Santa Clara USA).
Changes in gene expression over time were expressed as fold
changes 6 SEM from pre values using the delta delta CT method
[58] with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as
a housekeeping gene. GAPDH expression was not different from
PRE at any of the post-intervention time-points.
Nuclear and Cytoplasmic Extraction
Nuclear and cytoplasmic extraction was performed using a
commercially available kit with minor modifications (NE-PER
Nuclear and Cytoplasmic Extraction Reagents – Thermo Fischer
Scientific Inc., Wilmington USA). Between 20 mg and 60 mg of
tissue were transferred into a 2 mL microcentrifuge tube while still
frozen. 106 the volume in mL of the weight of the sample was
added to the sample for CER I buffer (from kit with the addition of
one protease and one phosphatase tablet dissolved in it). The
muscle was then minced using mincing scissors in the 2 mL
microcentrifuge tube for about 15 seconds. The sample was then
homogenized four times for five seconds using a rotary
homogenizer (PRO250, PRO Scientific Inc., Oxford USA). The
homogenate was then transferred to a 1.5 mL microcentrifuge
tube and vortexed for fifteen seconds. Following vortexing, 20 mL
of CER II buffer was added per sample (from kit with the addition
of half a protease and half a phosphatase tablet dissolved). The
sample was then vortexed for five seconds and put on ice for one
minute. The tube was again vortexed for five seconds and then
centrifuged for five minutes at 16 000 g at 4uC. The supernatant
(cytoplasmic extract) was immediately transferred to pre-chilled
1.5 mL microcentrifuge tubes and frozen down at 280uC. The
remaining pellet was then washed with 400 mL of a PBS cocktail
containing one protease and one phosphatase tablet dissolved,
spun for five minutes at 16 000 g at 4uC. The liquid was decanted
with the wash repeated three more times. On the last wash the
pellet was resuspended prior to the final spin. After the final spin
the pellet was suspended in 200 mL of ice-cold NER buffer (from
kit with the addition of 50 mL of 10% SDS). The pellet was then
broken up using Teflon pestles. The samples were then vortexed
for 15 seconds and placed on ice for ten minutes. This was
repeated three more times. The samples were then centrifuged at
16 000 g for ten minutes at 4uC. The supernatant (nuclear extract)
was then immediately transferred to a pre-chilled 1.5 mL
microcentrifuge tube and frozen down at 280uC. Bradford
analysis was then conducted on the samples to obtain the
concentration using a spectrophotometer (UltraSpec 300 pro,
Biochrome Ltd., Cambridge UK).
Western Blotting
Equal amounts (75 mg) of cytoplasmic or nuclear homogenate in
46Laemlli buffer were boiled at 95uC for 5 minutes then loaded
in the wells of at 7.5% gel. Nuclear samples were precipitated via
the acetone precipitation [59] method to increase their concen-
trations so that 75 mg of nuclear protein could be loaded in each
well. Briefly, samples were mixed with four volumes of ice cold
acetone and incubated for 1 hour. Samples were spun at 13,000 g
for 10 minutes and the resulting pellet was dried for 20 minutes.
Dried pellets were reconstituted in 46Laemlli buffer and ddH2O.
Phosphorylated and total Jak2 were analyzed in the cytoplasm
only, while phosphorylated and total Stat3 were analyzed in both
the nucleus and cytoplasm. Nuclear p-STAT3 was run with
cytoplasmic pSTAT3 from the same subject. Gels were run at
125 V for approximately 1 hour, and then transferred to
polyvinylidene fluoride (PVDF; Millipore, Etobicoke, Canada)
membranes at 70 V for 1 hour. Membranes were blocked with
5% non-fat powdered milk in PBS (10 mM, pH 7.4) for 1 hour at
4uC, then incubated in primary, phospho-specific antibody
(phospho-Stat3 Tyr705, 1:1000, and phospho-Jak2 Tyr1007/
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in 5% bovine serum albumin for cytosolic fractions and 5% non-
fat dry milk in PBS for nuclear STAT3 blots (BSA, Santa Cruz
Biotechnology, Santa Cruz, USA) at 4uC. After multiple washes,
blots were incubated in goat anti-rabbit HRP (1:50,000; Abcam
Inc., Cambridge USA) in 5% BSA for 90 minutes at room
temperature. After multiple washes, proteins were detected with
ECL (SuperSignal West Dura; Thermo Fisher Scientific, Rock-
ford, USA) using FluorChem SP (Alpha Innotech Corporation,
San Leandro, USA). After detection of phosphorylated proteins,
blots were washed and stripped with Restore Western Blot
Stripping Buffer (Thermo Fisher Scientific, Rockford, USA) for
20 minutes at room temperature. Membranes were washed and
re-probed with total-specific antibodies (Stat3, 1:1000, and Jak2
D2E12 rabbit mAb, 1:500, Cell Signaling Techonlogy, Boston,
USA) in the same manner as phospho-specific protein detection.
Following total protein detection, ponceau staining confirmed
equal loading. Protein bands corresponding to the predicted
molecular weight of Jak2 (,125 kDa) and Stat3 (,86 kDa) were
quantified using the AlphaEase FC Software, Version 5.0.2 (Alpha
Innotech Corporation, San Leandro, USA) with background
correction. As we were interested in determining the changes in
the amount of activated protein, the ratio of phosphorylated to
total protein was determined.
Immunohistochemistry
7 mm muscle cross-sections were stained with antibodies
against Pax7 (neat; cell supernatant from cells obtained from
the DSHB, Iowa City USA); IL-6 (500 ng/mL, MAB 2061, R&D
Systems, Minneapolis USA); p-STAT3 (1:100, Cell Signaling
Technologies Inc., Danvers USA) and laminin (1:1000, L8271,
Sigma-Aldrich, Oakville Canada). Secondary antibodies used
were: Pax7 (AlexaFluor 488 or AlexaFluor 594, 1:500, Invitro-
gen, Molecular Probes Inc., Camarillo USA or when using two
mouse primary antibodies an immunoglobulin biotinylated
secondary antibody, 1:200, Dako Inc., Mississauga Canada;
followed by a streptavidin-FITC fluorochrome, 1:100, Carlsbad
Biosource. USA); and Laminin (AlexaFluor 594, 1:500, Invitro-
gen, Molecular Probes Inc., Camarillo USA). Histochemical
methods were adapted from previously published methods from
our lab [50,17,18,20]. Briefly, for co-immunofluorescent staining
(Pax7 and IL-6, Pax7 and Laminin), sections were fixed with 2%
paraformaldehyde (PFA, Sigma-Aldrich, Oakville Canada) for
10 min followed by several washes in PBS. Sections were then
covered for 60 min in a blocking solution containing, 2% BSA,
5% FBS, 0.2% Triton-X 100, 0.1% sodium azide. Following
blocking, sections were incubated in the primary antibody at 4uC
overnight. After several washes, sections were then incubated in
the appropriate secondary antibodies. Sections were then re-fixed
in 2% PFA (Sigma-Aldrich, Oakville Canada) to prevent
migration of the secondary antibodies and re-blocked in 10%
GS in 0.01% Triton-X 100 (Sigma-Aldrich, Oakville Canada).
The sections were then incubated in the second primary
antibody, followed by incubation in the appropriate secondary
antibody. Sections were then washed with PBS and 49,6-
diamidino-2-phenylindole (DAPI, 1:20000) (Sigma-Aldrich, Oak-
ville Canada) for nuclear staining. Staining was verified using the
appropriate positive and negative controls to ensure specificity of
staining. Stained slides were viewed with the Nikon Eclipse 90i
Microscope (Nikon Instruments, Inc., Melville USA) and images
were captured and analyzed using the Nikon NIS Elements 3.0
software (Nikon Instruments, Inc., Melville USA). For cMyc
immunodetection, serial sections were used to visualize both Pax7
(with Laminin) and cMyc. A secondary-only control image has
been included to demonstrate the specificity of the cMyc antibody
(Figure S1f). Pax7/Laminin staining was performed as described
above, and cMyc was stained as follows: slides were dried and
fixed in acetone for 10 minutes. Slides were then washed several
times in 16 PBS followed by quenching of endogenous
peroxidases for 30 minutes using 0.3% H2O2 solution. After
washing, sections were then blocked in 10% goat serum in a 0.2%
Triton-X 100 (Sigma-Aldrich, Oakville Canada) solution for
30 minutes. cMyc antibody (cell supernatant, DSHB, Iowa City
USA) was used at 1:2 in a 1% BSA solution and was then
incubated for 2 hours at room temperature. Slides were then
washed several times in PBST. The secondary IGB goat anti-
mouse (DAKO Inc., Mississauga Canada) was incubated at 1:200
for an hour followed by incubation in the Vectastain Elite ABC
kit (Vector Laboratories, Burlington Canada) according to the
manufacturer’s instructions for 30 minutes. Following several
washes in PBST, slides were developed using the DAB kit (Vector
Laboratories, Burlington Canada) according to the manufactur-
er’s instructions. Slides were counterstained using Mayer’s
hematoxylin (Sigma-Aldrich, Oakville Canada).
Immunohistochemical Analysis
Immunohistochemical quantification and enumeration was
performed at all time points (PRE, T1, T3, T24) for IL6
+/Pax7
+
(n=12) and pSTAT3
+/Pax7
+ (n=9) and images were taken at
406 magnification. For cMyc
+/Pax7
+ stain 7 subjects were
analysed (n=7) at PRE and T24 with images being taken at
206magnification using full muscle cross-section stitched images.
Two separate blinded reviewers quantified the co-localization of
Pax7 and cMyc. Slides were viewed and images captured with the
Nikon Eclipse 90i Microscope (Nikon Instruments, Inc., Melville
USA) and Nikon NIS Elements 3.0 software (Nikon Instruments,
Inc., Melville USA).
Immunohistochemical quantification
Satellite cells were enumerated via double labelling with an anti-
Pax7 antibody and DAPI. At least 300 myonuclei per timepoint
were counted. Only those cells that were co-positive were counted
as satellite cells. Furthermore, only cells associated with individual
myofibers, that were not in the interstitial space, were counted as
positive. IL6
+/Pax7
+ cells were only counted as positive if they
were triple immunolabeled with DAPI and antibodies against IL-6
and Pax7. pSTAT3
+/Pax7
+ cells were only counted as positive if
they were triple immunolabeled with DAPI and antibodies against
pSTAT3 and Pax7. cMyc
+/Pax7
+ cells were only counted as
positive if they were triple immunolabeled with Mayers Hemotox-
ylin and antibodies again cMyc and Pax7 with Laminin defining
the SC niche. Non-fiber associated nuclei (interstitial nuclei) were
not included in the quantification. All data are represented as a
percentage of Pax7
+ cells.
Statistical Analysis
Statistical analysis and graphing were performed using
Sigmstat 3.1.0 analysis software (Systat, SPSS Inc., San Jose
USA) and Prism5 for Windows - version 5.01 (GraphPad
Software Inc., La Jolla USA). mRNA, protein, IL-6 and creatine
kinase plasma concentrations, IL-6
+/Pax7
+ and pSTAT
+/Pax7
+
enumeration were analysed using a 1-way repeated measures
analysis of variance (ANOVA). cMyc
+/Pax7
+ enumeration was
analysed via a two-tailed T-test. Statistical significance was set at
P,0.05. Tukey’s HSD post hoc test was used to analyse main
effects and significant interactions. Results are presented as mean
6SEM.
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Figure S1 (S1a) Pearson correlation between the serum
concentrations of IL-6 (pg/mL) and cMyc (U/L); R
2=0.3055;
p,0.001. The correlation is representative of the individual data
points presented as mean values 6 SD (error bars). (S1b)
Representative image of nuclear and cytoplasmic preparations
with the cytoplasmic marker LDH present only in the cytoplasm
and the nuclear marker p84 present only in the nuclear fraction.
(S1c) Pearson correlation between the mRNA regulation (fold
change) of IL-6 and SOCS3; R
2=0.5984, p,0.001. The
correlation is representative of the individual data points presented
as mean values 6 SD (error bars). (S1d) Pearson correlation
between the mRNA regulation (fold change) of IL-6 and cMyc;
R
2=0.2876, p,0.001. The correlation is representative of the
individual data points presented as mean values 6 SD (error bars).
(S1e) Pearson correlation between the mRNA regulation (fold
change) of SOCS3 and cMyc; R
2=0.5406, p,0.001. The
correlation is representative of the individual data points presented
as mean values 6 SD (error bars). (S1f) Representative image of a
muscle cross section stained with only the secondary and
hematoxylin during the cMyc staining protocol. Note that there
is no brown colour change indicating no false positivity caused
from the addition of the secondary antibody.
(TIF)
Table S1 mRNA species that were analysed with their forward
and reverse sequences, cDNA (ng) concentration used and
annealing temperature (uC).
(DOC)
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